A New Chapter, A New CEO For Dendreon
This article was originally published in The Pink Sheet Daily
Executive Summary
Former Savient and ImClone CEO Johnson will be responsible for driving commercial expansion of Provenge in the U.S. and Europe. Mitchell Gold steps down as CEO after successfully getting the prostate cancer drug to market following an arduous FDA review but struggling with commercial complexities.